No abstract available
MeSH terms
-
Adenine / analogs & derivatives
-
Adenine / therapeutic use
-
Alkynes
-
Anti-HIV Agents / administration & dosage
-
Anti-HIV Agents / adverse effects
-
Anti-HIV Agents / therapeutic use*
-
Benzoxazines / therapeutic use
-
Clinical Trials, Phase III as Topic
-
Cyclopropanes
-
Delavirdine / therapeutic use
-
Deoxycytidine / analogs & derivatives
-
Deoxycytidine / therapeutic use
-
Drug Design
-
Drug Resistance, Viral / genetics
-
Emtricitabine
-
HIV Infections / drug therapy*
-
HIV Protease Inhibitors / therapeutic use
-
HIV-1 / drug effects*
-
HIV-1 / genetics
-
Humans
-
Multicenter Studies as Topic
-
Mutation
-
Nevirapine / therapeutic use
-
Nitriles / administration & dosage
-
Nitriles / adverse effects
-
Nitriles / therapeutic use*
-
Organophosphonates / therapeutic use
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Reverse Transcriptase Inhibitors / administration & dosage
-
Reverse Transcriptase Inhibitors / adverse effects
-
Reverse Transcriptase Inhibitors / therapeutic use*
-
Rilpivirine
-
Tenofovir
-
Viral Load / drug effects*
Substances
-
Alkynes
-
Anti-HIV Agents
-
Benzoxazines
-
Cyclopropanes
-
HIV Protease Inhibitors
-
Nitriles
-
Organophosphonates
-
Pyrimidines
-
Reverse Transcriptase Inhibitors
-
Deoxycytidine
-
Nevirapine
-
Tenofovir
-
Delavirdine
-
Rilpivirine
-
Emtricitabine
-
Adenine
-
efavirenz